Nonmelanoma skin cancers (NMSCs) are some of the most commonly diagnosed malignancies. In general, early-stage NMSCs have favorable outcomes; however, a small subset of patients develop resistant, advanced, or metastatic disease, or aggressive subtypes that are more challenging to treat...
Immunotherapy has transformed lung cancer care in recent years. In addition to providing durable responses and prolonged survival outcomes for a subset of patients with heavily pretreated non-small cell lung cancer (NSCLC), immune checkpoint inhibitors (ICIs)— either as monotherapy or in...
Depending on a variety of factors, there are various options for the treatment of genitourinary cancers (included bladder, kidney, and prostate cancers) including immunotherapy. This guide, published by Patient Resource Publishing in partnership with the Society for Immunotherapy of Cancer (SITC...
2020_Immuno_GU.pdf
Presentation slides and video from the 2021-2022 Advances in Cancer Immunotherapy ™ : A Focus on Immune Checkpoint Inhibitors held virtually on April 23, 2022 are available here. Program Organizers Tina Cascone, MD, PhD – The University of Texas MD Anderson Cancer Center ...
18 attachments
On October 6, 2021, leading experts from the SITC Immune Checkpoint Inhibitor-related Adverse Events Guideline Expert Panel presented the "SITC Clinical Practice Guideline Webinar – Case Studies in Immune Checkpoint Inhibitor-related Adverse Events." This high-level webinar covered advanced...
2 attachments
On September 16, 2021, leading experts from the SITC Immune Checkpoint Inhibitor-related Adverse Events Guideline Expert Panel presented the "SITC Clinical Practice Guideline Webinar – Practical Management Pearls for Immune Checkpoint Inhibitor-related Adverse Events." This high-level webinar...
On August 13, 2021, leading experts in cancer immunotherapy presented an overview of the publication "Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immune checkpoint inhibitor-related adverse events" during a live webinar. The recorded webinar and presentation...
On Monday, June 21, 2021 from 4 – 5 pm ET, leading experts from the SITC Lymphoma Immunotherapy Guideline Expert Panel presented "SITC Clinical Practice Guideline Webinar – Practical Management Pearls for Immunotherapy for the Treatment of Lymphoma." This high-level webinar was designed so that...
Presentation slides and video from the 2020-2021 Advances in Cancer Immunotherapy ™ Series - Los Angeles, CA held virtually on May 5, 2021 are available here. Program Organizers Edward B. Garon, MD – University of California Los Angeles Blanca A. Ledezma, NP – Ronald Reagan...
22 attachments
Presentation slides and video from the 2020-2021 Advances in Cancer Immunotherapy ™ Series - Detroit, MI held virtually on May 1, 2021 are available here. Program Organizer Shirish Gadgeel, MD – Henry Ford Cancer Institute Program Summary Specifically designed by the...
Join
Renew
Member Directory
My Profile
Email Sign-up
Volunteer
Support SITC
Contact Us